James Song joined Teikoku Pharma USA (TPU) in 2008 and currently serves as Vice President Clinical, Regulatory and Project Management. Mr. Song brings over 30 years of clinical development experience with primary focus on anti-cancer, central nervous system, and transdermal delivery systems. During his time at TPU, Mr. Song has demonstrated strong leadership in the overall aspects of clinical development and has held various positions of increased responsibilities, most recently as Sr. Director of Biometrics and Clinical Affairs. Mr. Song was instrumental in the clinical development of a product for Alzheimer’s disease, working in collaboration with Eisai. Prior to joining TPU, Mr. Song worked for Solvay Pharmaceuticals, Matrix Pharmaceuticals, Alza Corporation (a Johnson & Johnson company) and Elan Pharmaceuticals. Mr. Song received a bachelor’s degree in Business Administration and a Master of Business Administration from Oklahoma City University and a Master of Science from Georgia State University.